Virax Biolabs Group Limited (VRAX)
(Delayed Data from NSDQ)
$0.78 USD
-0.01 (-0.78%)
Updated Aug 8, 2025 03:40 PM ET
After-Market: $0.79 +0.01 (0.78%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Virax Biolabs Group Limited's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
VRAX 0.78 -0.01(-0.78%)
Will VRAX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VRAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VRAX
Zacks Investment Ideas feature highlights: Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions
WHO Declares Monkeypox Public Emergency: 5 Mpox Stocks to Watch
VRAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for VRAX
Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial ...
Virax Biolabs (VRAX) Faces Nasdaq Compliance Challenge | VRAX Stock News
Virax Biolabs receives noncompliance notice from Nasdaq
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price ...
Virax Biolabs receives Nasdaq letter over non-compliance with minimum bid price rule